IASO Biotherapeutics
Mr. Zou joined IASO Biotherapeutics in 2017 and is currently the company’s Director and Vice President for CMC. He has nearly 20 years of experience in GMP management.
Mr. Zou graduated from the National University of Singapore with a Master’s degree in Chemistry, and was previously Quality Director and Quality Authorizer of Sinovac Biotech Ltd. (NASDAQ: SVA). He was also a GMP Expert of Beijing Municipal Medical Products Administration.
This person is not in any offices
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.